AKT1 and cancer: CK2 stimulates SLC39A7 activating which promotes Zn releasing from the ER into the cytoplasm and the released Zn inhibits phosphorylation of protein and increased the activity of tyrosine kinases, Akt survival and extracellular regulated kinase 1/2 growth signaling pathways, which promote cancer progression [45].